What is the B-nicotinamide mononucleotide reduced*form type I?

B-nicotinamide mononucleotide reduced*form type I is , while it's Molecular Formula is . Used in Anti-Aging Applications: B-nicotinamide mononucleotide reduced form type I is utilized as an anti-aging agent for its potential to increase NAD+ levels in cells. This enhancement is believed to improve mitochondrial function and support overall cellular health, which may contribute to the slowing down of the aging process and the promotion of longevity. Used in Cellular Health Enhancement: In the health and wellness industry, B-nicotinamide mononucleotide reduced form type I is used as a cellular health enhancer. Its ability to boost NAD+ levels is thought to support various cellular processes, including energy production and DNA repair, thereby potentially improving overall health and well-being. Used in Therapeutic Research: B-nicotinamide mononucleotide reduced form type I is employed as a subject of therapeutic research in the pharmaceutical industry. Its potential to influence key cellular processes makes it a candidate for the development of treatments targeting a range of conditions related to cellular health and function. Used in Nutraceutical Formulations: In the nutraceutical sector, B-nicotinamide mononucleotide reduced form type I is used as an ingredient in dietary supplements. These supplements aim to provide the benefits of increased NAD+ levels to consumers seeking to support their health and potentially extend their lifespan through the enhancement of cellular processes.

What is the CAS number for B-nicotinamide mononucleotide reduced*form type I?

The CAS number of B-nicotinamide mononucleotide reduced*form type I is 108347-85-9.

What is B-nicotinamide mononucleotide reduced*form type I (108347-85-9) used for?

B-nicotinamide mononucleotide reduced form type I, also known as NMN, is a chemical compound that serves as a reduced form of nicotinamide mononucleotide. It acts as a precursor to nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that plays a crucial role in numerous cellular processes such as energy production, DNA repair, and gene expression. B-nicotinamide mononucleotide reducedform type I is recognized for its potential to enhance NAD+ levels within cells, which may contribute to improved mitochondrial function and overall cellular health. Due to its capacity to replenish NAD+ levels and support a variety of cellular functions, B-nicotinamide mononucleotide reduced form type I has emerged as a promising candidate for anti-aging and longevity-promoting properties, warranting further research and exploration for potential therapeutic applications.

What is the B-nicotinamide mononucleotide reduced*form type I?

B-nicotinamide mononucleotide reduced*form type I is , while it's Molecular Formula is . Used in Anti-Aging Applications: B-nicotinamide mononucleotide reduced form type I is utilized as an anti-aging agent for its potential to increase NAD+ levels in cells. This enhancement is believed to improve mitochondrial function and support overall cellular health, which may contribute to the slowing down of the aging process and the promotion of longevity. Used in Cellular Health Enhancement: In the health and wellness industry, B-nicotinamide mononucleotide reduced form type I is used as a cellular health enhancer. Its ability to boost NAD+ levels is thought to support various cellular processes, including energy production and DNA repair, thereby potentially improving overall health and well-being. Used in Therapeutic Research: B-nicotinamide mononucleotide reduced form type I is employed as a subject of therapeutic research in the pharmaceutical industry. Its potential to influence key cellular processes makes it a candidate for the development of treatments targeting a range of conditions related to cellular health and function. Used in Nutraceutical Formulations: In the nutraceutical sector, B-nicotinamide mononucleotide reduced form type I is used as an ingredient in dietary supplements. These supplements aim to provide the benefits of increased NAD+ levels to consumers seeking to support their health and potentially extend their lifespan through the enhancement of cellular processes.

What is the CAS number for B-nicotinamide mononucleotide reduced*form type I?

The CAS number of B-nicotinamide mononucleotide reduced*form type I is 108347-85-9.

What is B-nicotinamide mononucleotide reduced*form type I (108347-85-9) used for?

B-nicotinamide mononucleotide reduced form type I, also known as NMN, is a chemical compound that serves as a reduced form of nicotinamide mononucleotide. It acts as a precursor to nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that plays a crucial role in numerous cellular processes such as energy production, DNA repair, and gene expression. B-nicotinamide mononucleotide reducedform type I is recognized for its potential to enhance NAD+ levels within cells, which may contribute to improved mitochondrial function and overall cellular health. Due to its capacity to replenish NAD+ levels and support a variety of cellular functions, B-nicotinamide mononucleotide reduced form type I has emerged as a promising candidate for anti-aging and longevity-promoting properties, warranting further research and exploration for potential therapeutic applications.